INSIGHTS ON CLINICAL TRIAL PARTNERING
-
How A Biotech Startup Transformed Its Clinical Trial Supply Management
Don’t let your trial get lost in the shuffle of legacy vendors. See how a high-touch, consultative approach can protect your study’s future.
-
Building A Gold Standard Trial Experience In Japan
Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.
-
Make GCP Training Easier For Sites Before Meetings
Completing GCP training before investigators’ meetings reduces compliance work, aligns site expectations, and frees meeting time for protocol planning and study startup preparation.
-
How To Capture Growth In The Expanding Metabolic Drug Market
Driven by GLP-1 success and rising obesity rates, R&D investment in metabolic disease therapies now rivals oncology, demanding rapid development to overcome market challenges.
-
Bridging The Engagement Gap In Obesity Trials2/13/2026
Improve obesity trial retention with actionable guidance: provide proactive plateau counseling, simplify data capture, and leverage existing provider-patient relationships to sustain motivation.
-
Accelerator™ Drug Development 360° CDMO And CRO Solutions3/4/2026
Review this coordinated suite of integrated solutions that brings together CDMO and CRO capabilities across clinical research, manufacturing, and clinical supply.
-
5 Projections For 2026: Navigating The New Normal In Clinical Trials2/18/2026
In 2026, clinical trial success depends on moving from AI hype to proven utility. Unified data and seamless site experiences are no longer optional; they are the keys to trial resilience.
-
Patient Centric Clinical Trials: Why Transportation Is A Timeline Risk2/24/2026
Address transportation barriers to reduce protocol deviations and data gaps. Strategies that lower travel burden protect study timelines and improve visit adherence for better trial outcomes.
-
7 Practical Implications Of ICH E6(R3) For Early-Phase Trial Design8/10/2026
A risk-based quality approach can enhance participant protection, data integrity, and development success through focused oversight, strong governance, and clear documentation.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Looking for faster trial startup, diverse participant pools, and consistent site quality? Explore a vaccine research network designed to keep your study on time and on target.
-
Altasciences has over 25 years of experience in metabolic diseases and supports every stage of the development process, from discovery to clinical trials — and beyond.
-
Accelerator™ Drug Development provides a strategic, end-to-end partnership model that helps sponsors optimize resources, overcome development challenges, and advance promising therapies.
-
Global Strategies to Align Your Goals With Regulatory Requirements
Ergomed’s regulatory consultancy services are guided by a team of seasoned consultants, each bringing a wealth of experience from regulatory agencies and in-house roles. This expertise ensures a proactive and flexible solution tailored to your project’s unique needs and timelines, instilling confidence in our services.
-
Getting a novel therapy through the clinical development process to approval is complicated. Unearth how to advance novel medical therapies from Phase I-III clinical development to market with confidence.